3,011 research outputs found

    Binuclear Manganese(III) Complexes as Electron Donors in D1/D2/Cytochrome b559 Preparations Isolated from Spinach Photosystem II Membrane Fragments

    Get PDF
    The capability of different manganese complexes to act as PS II electron donors in D1/D2/ cytochrome b 559 complexes has been analyzed by measuring actinic light-induced absorption changes at 680 nm (650 nm) and 340 nm, reflecting the photoaccumulation of Pheophytin- (Pheo-) and the reduction of NADP+ respectively. The data obtained reveal: a) the donor capacity of synthetic binuclear Mn(III)2 complexes containing aromatic ligands significantly exceeds that for MnCl2 in both cases, i.e. Pheo- photoaccumulation and NADP+ reduction; b) manganese complexes can serve as suitable electron donors for light-induced NADP+ reduction catalyzed by D1/D2/cytochrome b559 complexes and ferredoxin plus ferredoxin- NADP+ reductase under anaerobic conditions and c) the specific turnover rate of the system leading to NADP+ reduction is extremely small. The implications of these findings are briefly discussed

    Characterizations of Ultrasonically Prepared Nanostructured ZnO powder and NH3 Sensing Performance of its Thick Film Sensor

    Get PDF
    AbstractIn the present investigation nanostructured ZnO powder was prepared using ultrasonic atomization method. An aqueous solution of Zn (NO3)2 *6H2O was atomised using ultrasonic atomizer. The prepared nanostructured ZnO powder was collected using a simple but novel trapping system. The powder was characterized using XRD, TEM, SEM and EDAX. Nanostructured thick-film sensors of this powder were prepared by using the simple screen printing technique. The gas sensing performance of this film was tested. The sensor was found to be most sensitive to NH3

    Imaging Biomarkers in Acute Ischemic Stroke Trials: A Systematic Review

    Get PDF
    Imaging biomarkers are increasingly used to provide a better understanding of the pathophysiology of acute ischemic stroke. However, this approach of routinely using imaging biomarkers to inform treatment decisions has yet to be translated into successful randomized trials. The aim of this study was to systematically review the use of imaging biomarkers in randomized controlled trials in patients with acute ischemic stroke, exploring the purposes for which the imaging biomarkers were used.We performed a systematic review of imaging biomarkers used in randomized controlled trials of acute ischemic stroke, in which a therapeutic intervention was trialed within 48 hours of symptom onset. Data bases searched included MEDLINE, EMBASE, strokecenter.org, and the Virtual International Stroke Trials Archive (1995-2014).Eighty-four studies met the criteria, of which 49 used imaging to select patients; 31, for subgroup analysis; and 49, as an outcome measure. Imaging biomarkers were broadly used for 8 purposes. There was marked heterogeneity in the definitions and uses of imaging biomarkers and significant publication bias among post hoc analyses.Imaging biomarkers offer the opportunity to refine the trial cohort by minimizing participant variation, to decrease sample size, and to personalize treatment approaches for those who stand to benefit most. However, within imaging modalities, there has been little consistency between stroke trials. Greater effort to prospectively use consistent imaging biomarkers should help improve the development of novel treatment strategies in acute stroke and improve comparison between studies
    • …
    corecore